Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

5086 results

Sort By:

A Study to Evaluate Pregabalin in Painful Diabetic Peripheral Neuropathy

Study ID: NCT06383702
Start Date: May 15, 2024
End Date: April 15, 2025
Study Type

Interventional

Study Phase

Phase 3

No. of Participants

358

Intervention / Treatment

pregabalin sustained-release tablets

Placebo

Sponsor

CSPC Ouyi Pharmaceutical Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

A Phase III Study of ESG401 for Locally Advanced or Metastatic HR+/HER2- Breast Cancer

Study ID: NCT06383767
Start Date: June 30, 2024
End Date: December 31, 2026
Study Type

Interventional

Study Phase

Phase 3

No. of Participants

378

Intervention / Treatment

ESG401

Eribulin, capecitabine, gemcitabine or vinorelbine (Treatment of Physician's Choice)

Sponsor

Shanghai Escugen Biotechnology Co., Ltd

Source: clinicaltrials.gov

Share:
Add to list

Organ Preservation With Tislelizumab and Total Neoadjuvant Therapy in Patients With Low Rectal Cancer: RELIEVE -01 Study

Study ID: NCT06390982
Start Date: May 2024
End Date: December 2028
Study Type

Interventional

Study Phase

Phase 2

No. of Participants

46

Intervention / Treatment

Radiotherapy

Tislelizumab

Capecitabine

Oxaliplatin

Capecitabine

Sponsor

Fudan University

Source: clinicaltrials.gov

Share:
Add to list

Effects of Remote Cardiac Ischemic Preconditioning

Study ID: NCT06390358
Start Date: May 1, 2024
End Date: May 1, 2025
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

24

Intervention / Treatment

Tefillin

Sponsor

Jack Rubinstein

Source: clinicaltrials.gov

Share:
Add to list

Immunosensitized Radiotherapy Combined With Evoximab (AK112) and Chemotherapy Neoadjuvant Therapy for Stage II-III Non-small Cell Lung Cancer

Study ID: NCT06391008
Start Date: April 30, 2024
End Date: June 30, 2025
Study Type

Interventional

Study Phase

Phase 2

No. of Participants

44

Intervention / Treatment

Stereotactic radiotherapy

Evoximab

Pemetrexed

Albumin Paclitaxel

Carboplatin

Sponsor

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Source: clinicaltrials.gov

Share:
Add to list

Composite Repair Using Silane Coupling Agent

Study ID: NCT06392685
Start Date: July 2024
End Date: July 2025
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

75

Intervention / Treatment

Silane coupling agent

Adhesive containing silane.(Intervention 1 )

Acid resistance silane containing adhesive.(Intervention 2)

Sponsor

Cairo University

Source: clinicaltrials.gov

Share:
Add to list

Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia

Study ID: NCT06392711
Start Date: May 2024
End Date: November 2028
Study Type

Interventional

Study Phase

Phase 1

No. of Participants

36

Intervention / Treatment

Mesenchymal Stromal Cells (MSC) Dose Level 0

Mesenchymal Stromal Cells (MSC) Dose Level 1

Sponsor

University of Wisconsin, Madison

Source: clinicaltrials.gov

Share:
Add to list

Investigating Brain Insulin Resistance In Alzheimer Disease With IntraNasal Insulin : A Multimodal Neuroimaging Study

Study ID: NCT06391853
Start Date: June 1, 2024
End Date: October 1, 2026
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

Insulin

Placebo

Sponsor

Erasme University Hospital

Source: clinicaltrials.gov

Share:
Add to list

PCSK9 Inhibitors in Combination With Advanced Treatment Strategies for the Treatment of Advanced Colorectal Cancer With pMMR/MSS

Study ID: NCT06391905
Start Date: May 6, 2024
End Date: May 6, 2028
Study Type

Interventional

Study Phase

Phase 2

No. of Participants

60

Intervention / Treatment

PCSK9 inhibitor in combination with standard advanced first-line regimen group

standard advanced first-line regimen group

Sponsor

Guangdong Provincial People's Hospital

Source: clinicaltrials.gov

Share:
Add to list

The Danish Version of the Surgical Fear Questionnaire

Study ID: NCT06392698
Start Date: June 10, 2024
End Date: June 20, 2025
Study Type

Observational

Study Phase

N/A

No. of Participants

200

Intervention / Treatment
Sponsor

Gødstrup Hospital

Source: clinicaltrials.gov

Share:
Add to list